ePoster

ASSESSMENT OF METABOLISM AND VIABILITY IN LIVE-3D BRAIN ORGANOIDS WITHIN A CUSTOM BIOREACTOR FOR ULTRA-HIGH-FIELD MRI/MRS

Pauline Léaland 11 co-authors

Lausanne University Hospital (CHUV)

FENS Forum 2026 (2026)
Barcelona, Spain
Board PS07-10AM-025

Presentation

Date TBA

Board: PS07-10AM-025

Poster preview

ASSESSMENT OF METABOLISM AND VIABILITY IN LIVE-3D BRAIN ORGANOIDS WITHIN A CUSTOM BIOREACTOR FOR ULTRA-HIGH-FIELD MRI/MRS poster preview

Event Information

Poster Board

PS07-10AM-025

Abstract

The development of three-dimensional organoid culture over the past decade has enabled researchers to outreach the possibility to study cellular and molecular mechanisms in cells within their complex environment. Indeed, its accurate reproduction of the organization of brain cells makes it a relevant model for studying the development, physiology and maturation of the brain.
However, we still lack methods to follow metabolism in this model longitudinally, non-invasively. To tackle this, we developed an in-house-designed bioreactor adapted to preclinical horizontal-bore MR scanner to maintain organoids under controlled environmental conditions throughout the scan. The aims of this project are first to maintain the cellular integrity and viability of the organoids over a 6-hour MR-imaging period in the bioreactor, and then to study the metabolism of the organoids using proton magnetic resonance spectroscopy (1H-MRS).
The organoids were obtained by dissection of 15-fetal-day-old rats’ embryos telencephales using Honneger’s protocol and normal culture conditions were maintained during the MR-scan by circulating culture medium at 1 mL/min through the bioreactor.
We were able to characterize metabolic profile inside organoids using 1H-MRS spectra which suggest an early stage of development. We confirmed these metabolic data with 1H-NMR and mass spectrometry and assessed organoids viability using propidium iodide dye to ensure that we maintained the organoids alive during the MR scan.
Next steps will be to study the metabolism and the microstructure of these organoids along their development both using MRS and diffusion-weighted MRI/MRS techniques and histological analysis; but also, in a context of neurodevelopment disease.

(A) Our custom-designed bioreactor: ⌀8.5-mm cylindrical measurement chamber is encircled by a ⌀13-mm RF coil. Normal culture conditions are maintained by circulating culture medium (aired with 10% CO2) at 1mL/min through the bioreactor, maintaining it at 37°C. (B) Representative MRS spectra in live organoids acquired using a STEAM sequence and analysed with LCModel for metabolite identification. Spectrum shows low NAA with high lactate, glycine and hypotaurine levels. The contribution from the culture medium (purple) is minimal (C) Immunostaining at 0h (introduction in the bioreactor) and 6h with propidium iodide (PI) dye (late stage of apoptosis/necrosis), and DAPI (cell nuclei). Cell death progression aligns with physiological patterns.

Recommended posters

Cookies

We use essential cookies to run the site. Analytics cookies are optional and help us improve World Wide. Learn more.